Neoplasms, Glandular and Epithelial 
Welcome,         Profile    Billing    Logout  

12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neoplasms, Glandular and Epithelial
NCT01835171: Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer

Active, not recruiting
2
25
US
Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam Radiotherapy, External Beam RT, external radiation, External Radiation Therapy, external-beam radiation, Internal Radiation Therapy, BRACHYTHERAPY, Internal Radiation, Internal Radiation Brachytherapy, Radiation Brachytherapy, Laboratory Biomarker Analysis, Triapine, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, 3-AP, 3-Apct, OCX-191
National Cancer Institute (NCI)
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB2 Cervical Cancer, Stage II Vaginal Cancer, Stage IIA1 Cervical Cancer, Stage IIA2 Cervical Cancer, Stage IIB Cervical Cancer, Stage III Vaginal Cancer, Stage IIIA Cervical Cancer, Stage IIIB Cervical Cancer, Stage IVA Cervical Cancer, Stage IVA Vaginal Cancer, Vaginal Adenocarcinoma, Vaginal Adenosquamous Carcinoma, Vaginal Squamous Cell Carcinoma
01/16
 
NCT02258243: Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Active, not recruiting
2
3
US
aminolevulinic acid hydrochloride, 5-ALA HCl, ALA HCl, aminolevulinic acid HCl, photodynamic therapy, Light Infusion Therapy™, PDT, therapy, photodynamic, laboratory biomarker analysis, questionnaire administration
Case Comprehensive Cancer Center, National Cancer Institute (NCI)
Basal Cell Carcinoma of the Skin, Nevoid Basal Cell Carcinoma Syndrome
10/16
12/17
NCT01322542: YF476 in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome

Recruiting
2
30
US
YF476
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Carcinoid
12/17
12/17
NCT00915993: MRI in Predicting Response to Sunitinib Malate in Patients With Stage IV Kidney Cancer

Recruiting
N/A
40
US
sunitinib malate, mutation analysis, immunohistochemistry staining method, laboratory biomarker analysis, pharmacological study, dynamic contrast-enhanced magnetic resonance imaging
University of Pennsylvania, National Cancer Institute (NCI)
Kidney Cancer
05/11
 
NCT00655252 / 2007-005460-28: Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy

Checkmark RCC
Jan 2013 - Jan 2013: RCC
Checkmark Data - ESMO 2012
Sep 2012 - Sep 2012: Data - ESMO 2012
Checkmark Data -ESMO 2012
More
No Longer Available
N/A
US, Canada, Europe, RoW
Everolimus
Novartis Pharmaceuticals
Metastatic Renal Cell Cancer
 
 
NCT01473043: Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment

No Longer Available
N/A
Canada, RoW
Axitinib, AG-013736
Pfizer
Renal Cell Carcinoma
03/14
03/14
NCT02082691: Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma

No Longer Available
N/A
US
G-202
Devalingam Mahalingam, GenSpera, Inc.
Hepatocellular Carcinoma
 
 
NCT01980732: 68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

No Longer Available
N/A
US
68Ga-DOTA TATE
Andrei Iagaru
Carcinoid Tumors, Islet Cell (Pancreatic NET), Other Neuroendocrine Tumors
 
 
NCT02329002: SPT Screening in Irradiated Hereditary Retinoblastoma Survivors

Recruiting
N/A
400
Europe
Magnetic resonance imaging
Amsterdam UMC, location VUmc, ODAS
Retinoblastoma
10/18
10/23
NCT02186925: A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.

Recruiting
N/A
1000
RoW
Meir Medical Center
Kidney Cancer, Prostate Cancer, Bladder Cancer
08/19
08/25
ACRIN6690, NCT01082224: Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy

Active, not recruiting
N/A
440
US
iodinated contrast dye, iodinated radiographic dye, motexafin gadolinium, Xcytrin, Eovist-enhanced MRI
American College of Radiology Imaging Network, National Cancer Institute (NCI)
Liver Cancer
12/23
12/23
NCT01000259: Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Recruiting
N/A
174
US
Laboratory Biomarker Analysis
Gynecologic Oncology Group, National Cancer Institute (NCI)
Stage IIIA Ovarian Cancer, Stage IIIB Ovarian Cancer, Stage IIIC Ovarian Cancer, Stage IV Ovarian Cancer
01/00
 

Download Options